Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | 7,284 | reported | 15 May 2026 | tx 10+2,584−11,395 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 33 | 453.45 USD | 10b5-1 |
| 24 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 582 | 485.11 USD | |
| 25 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 620 | 486.35 USD | |
| 18 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 1,182 | 473.68 USD | |
| 17 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,437 | 489.46 USD | |
| 17 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 1,110 | 483.75 USD | |
| 17 Feb 2026 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 2,584 | 0.00 USD | |
| 13 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 2,283 | 487.76 USD | |
| 11 Feb 2026 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,021 | 460.43 USD | |
| 10 Feb 2026 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 1,127 | 468.41 USD |